Normunity
Normunity is a clinical-stage biotechnology company developing novel anti-cancer therapies that work at the interface of the immune system and the tumor. In collaboration with the Lieping Chen lab at the Yale School of Medicine, Normunity has identified a novel class of "Immuno-smart targets" — tumo
Normunity is an API provider whose private shares are listed on 2 secondary markets: EquityZen, Nasdaq Private Market.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.
Work with this as data
Every listing here is available over the APIs.io API and to AI agents over MCP. Secondary Market is not yet its own endpoint on the v1 API. Reach it through catalog search and the tag graph, or the MCP server.